Kim Sheva

Legacy Heritage Oncology Center & Dr. Larry Norton Institute
Beersheba, D, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Risk-adapted SBRT ([Formula: see text]) for recurrent lung-only metastases in patients with frailty or ultracentral anatomy.

Risk-adapted SBRT ([Formula: see text]) for recurrent lung-only metastases in patients with frailty or ultracentral anatomy.

Journal: Radiation oncology (London, England)

Published: May 01, 2025

Radiation-Induced Cardiac Disease: Modern Techniques to Reduce Cardiac Toxicity.

Radiation-Induced Cardiac Disease: Modern Techniques to Reduce Cardiac Toxicity.

Journal: Practical radiation oncology

Published: October 15, 2024

Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.

Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.

Journal: Medicina (Kaunas, Lithuania)

Published: July 11, 2024

Expression Analysis of SSTR 1, 2 and 3 in Small-cell Lung Cancer Patients as Targets for Future Peptide Receptor Radionuclide Therapy.

Expression Analysis of SSTR 1, 2 and 3 in Small-cell Lung Cancer Patients as Targets for Future Peptide Receptor Radionuclide Therapy.

Journal: Anticancer research

Published: June 06, 2024

Molecular Changes in Breast Cancer Induced by Radiation Therapy.

Molecular Changes in Breast Cancer Induced by Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: June 13, 2023

Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.

Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectives.

Journal: Seminars in cancer biology

Published: April 20, 2023

Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase.

Radiation-Induced Nephropathy in the Murine Model Is Ameliorated by Targeting Heparanase.

Journal: Biomedicines

Published: January 09, 2023

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma.

Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma.

Journal: Frontiers in oncology

Published: November 18, 2022

Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience.

Dermatomyositis Associated with Lung Cancer: A Brief Review of the Current Literature and Retrospective Single Institution Experience.

Journal: Life (Basel, Switzerland)

Published: November 13, 2022

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.

A Retrospective, Single-Institution Experience of Bullous Pemphigoid as an Adverse Effect of Immune Checkpoint Inhibitors.

Journal: Cancers

Published: October 09, 2022

Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response.

Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response.

Journal: Anticancer research

Published: June 30, 2022

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.

Computational quantification and characterization of independently evolving cellular subpopulations within tumors is critical to inhibit anti-cancer therapy resistance.

Journal: Genome medicine

Published: January 20, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026